A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2002
10/30/2002	EP1251844A2 Laxative preparation containing l-arginine
10/30/2002	EP1251843A1 Compositions for delivery of a cortisol antagonist
10/30/2002	EP1251842A2 Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies
10/30/2002	EP1251841A1 Aqueous solution for treating degenerative or autoimmune diseases and as immunomodulatory agent
10/30/2002	EP1251837A2 Compounds and methods for modulating cerebral amyloid angiopathy
10/30/2002	EP1251835A2 Closure of bacterial ghosts
10/30/2002	EP1251834A1 Reduced form of coenzyme q in high bioavailability stable dosage forms and related applications
10/30/2002	EP1251833A1 Gellan gum dipped products
10/30/2002	EP1251832A2 Shell-and-core dosage form approaching zero-order drug release
10/30/2002	EP1251831A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor
10/30/2002	EP1251830A1 Continuous method for preparing pharmaceutical granules
10/30/2002	EP1251829A1 Electrospun pharmaceutical compositions
10/30/2002	EP1251828A1 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability
10/30/2002	EP1251827A2 Nasally administrable cyclic peptide compositions
10/30/2002	EP1251826A1 Diclofenamide suspension gel
10/30/2002	EP1251818A1 Galenic formulation
10/30/2002	EP1251780A1 LUMINESCENT i IN VIVO /i GLUCOSE MEASUREMENT
10/30/2002	EP1251750A1 Improved pediatric formula and methods for providing nutrition and improving tolerance
10/30/2002	EP1251741A2 Delivering substances to invertebrate organisms
10/30/2002	EP1251739A2 Poly(dipeptide) as a drug carrier
10/30/2002	EP1152731A4 A skin care composition that mediates cell to cell communication
10/30/2002	EP1140242B1 Polymer compositions for intraluminal stent
10/30/2002	EP1135193B1 Agents provided for treating tumors, based on liposomes, and containing tamoxifen
10/30/2002	EP1053030B1 Supporting material for medicinal purposes
10/30/2002	EP1011634B1 Preparation of pharmaceutical compositions
10/30/2002	EP0918509A4 Biocompatible devices with foam scaffolds
10/30/2002	EP0909167B1 Drug delivery devices and process of manufacture
10/30/2002	EP0851763B1 Method and composition for enhanced parenteral nutrition
10/30/2002	EP0828495B1 Stabilized solid dispersions of misoprostol
10/30/2002	EP0827393B1 Pharmaceutical composition prepared by addition of a flavour vehicle to a medicament
10/30/2002	EP0812195B1 Pharmaceutical composition for piperidinoalkanol compounds
10/30/2002	CN2518802Y Pneumatic drug inhalator
10/30/2002	CN1377352A Selective antagonists of A28 adenosine receptors
10/30/2002	CN1377283A Process to make a sustained release formulation
10/30/2002	CN1377281A Solid preparations containing chitosan power and process for producing the same
10/30/2002	CN1377270A B-carboline drug products
10/30/2002	CN1377267A Retard form containing 2-lipoic acid (derivatives)
10/30/2002	CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/30/2002	CN1377264A Method for treating endometriosis or infertility, or improving fertility
10/30/2002	CN1377262A Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses
10/30/2002	CN1377258A Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same
10/30/2002	CN1377257A Hybrid matrices and hybrid matrix mixtures
10/30/2002	CN1376735A Antibiotics-polymer composition
10/30/2002	CN1376519A Multi-enzyme complex capsule
10/30/2002	CN1376508A Capsule for treating cholasma and acne and its preparing process
10/30/2002	CN1376500A Capsule 'Jingyaoning' and its preparing process
10/30/2002	CN1376493A Exterior-applied plaster for treating appendicitis and its preparing process
10/30/2002	CN1376490A Preparing process and prescription of loquat syrup for treating cough
10/30/2002	CN1376488A Ointment for treating cracked nipple
10/30/2002	CN1376487A Detoxicating and skin-growing ointment for treating burn
10/30/2002	CN1376486A Detoxicating and skin-growing powder for treating burn
10/30/2002	CN1376483A Soft capsule of notoginseng
10/30/2002	CN1376477A Medicinal bag for relieving rheumatalgia and myalgia
10/30/2002	CN1376471A Soft capsule 'Shaganling'
10/30/2002	CN1376470A Ointment for dispelling wind and relieving rigidity of muscles and joints and its preparing process
10/30/2002	CN1376469A Slow release antibiotics preparation of bioactive substance
10/30/2002	CN1376468A Freeze dried hydroxy camptothecin powder for injection and its preparing process
10/30/2002	CN1376460A Fat emulsion for injection and its preparing process
10/30/2002	CN1376459A Preparation method for antibiotics composition
10/30/2002	CN1376397A Ganoderma tea and its preparing process
10/30/2002	CN1376396A Effervescent tea tablet and its preparing process
10/30/2002	CN1376392A Rose fruit oil capsule
10/30/2002	CN1093414C Suppository for treating prostatic disease and preparing method thereof
10/30/2002	CN1093407C Medicine for nourishing yin and strengthening body resistance and producing method thereof
10/30/2002	CN1093402C Gastritis treating tablet
10/30/2002	CN1093399C Small particle liposome aerosols for delivery of anti-cancer drugs
10/29/2002	US6472439 Orally administerable medicinal plant dry extracts, wherein the non-volatile phase of the extract is bound in a microdisperse form and/or in the form of a semisolid or solid solution to a first carrier which is soluble in or miscible
10/29/2002	US6472434 Vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives,
10/29/2002	US6472431 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/29/2002	US6472379 Angiogenesis inhibition
10/29/2002	US6472375 DNA vaccine and methods for its use
10/29/2002	US6472365 Pharmaceuticals and assays using enzyme subunits
10/29/2002	US6472181 Hybrid matrix implants and explants
10/29/2002	US6472000 Method of controlling release of bitterness inhibitors in chewing gum and gum produced thereby
10/29/2002	US6471996 Lactone and lactide copolymer; copolymer of lactic acid, glycolic acid, and serine; drug delivery to immune systen
10/29/2002	US6471995 Apparatus and method for preparing microparticles using liquid-liquid extraction
10/29/2002	US6471994 Microcrystalline cellulose and silicon dioxide with particle size of 1 nanometer to 100 microns; slurrying, drying
10/29/2002	US6471993 Microstructure having voids located within said semi-solid network; tissue engineering scaffolds
10/29/2002	US6471992 Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
10/29/2002	US6471991 Drug, water disintegratable, compressible carbohydrate, and a binder, tablet's face surfaces have a convex shape and tablet having given hardness and low friability; taste masking
10/29/2002	US6471990 A dialkylamide glycylspermine; dioctadecylamide glycylspermine particularly preferred to help the gene to be transported into the target cells
10/29/2002	US6471987 Ligating band comprises an elastomeric layer and an inner drug releasing layer; chemotherapeutic agent for treating a mucosa, polyp or other growth
10/29/2002	US6471984 Cataplasm and tape-aid containing a plasticizer
10/29/2002	US6471977 Parenteral release into the circulatory system of a cow of a bioactive bovine somatotropin, concentration of at least about 150 mg/ml; more than three days
10/29/2002	US6471976 Complex or salt of copper and a partially neutralized, water soluble polycarboxylic acid, polyacrylic acid, plants
10/29/2002	US6471970 Use of pharmaceutical compositions capable of being gelled in periodontology
10/29/2002	US6471969 Two-phase preparation
10/29/2002	US6471954 Water-soluble glycerine and plant extracts, oil soluble emulsifiers, squalane and avocado oil are separately and inter mixed under pressure, further adding alpha-tocopherol, tocopherol acetate, retinyl palmitate and retinyl acetate;
10/29/2002	US6471944 Aerosol powder with improved skin adhesion
10/29/2002	US6471943 Formulation and method for treating neoplasms by inhalation
10/29/2002	US6471689 Support structure that defines a drug reservoir and a capillary interface which facilitates vascular ingrowth while inhibiting blockage of drug delivery openings in the reservoir.
10/29/2002	US6471688 Osmotic pump drug delivery systems and methods
10/29/2002	US6471687 Implantable containment apparatus for a therapeutical device
10/29/2002	US6471686 Drug delivery device
10/29/2002	US6471685 Medical dressing assembly and associated method of using the same
10/29/2002	CA2283314C Ointment for the treatment of burns and of other skin diseases
10/29/2002	CA2263455C Liposomes containing a cisplatin compound
10/29/2002	CA2115053C Antimicrobial dialdehyde composition and methods of use
10/29/2002	CA2088128C Salts of glucopyranose derivatives and its intermediate
10/28/2002	WO2001082977A1 Liposomes containing hydrophobic iodo compound

1 ... 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 ... 2991